ARTICLE | Company News
PolyTherics, University College London deal
October 4, 2010 7:00 AM UTC
The university will use PolyTherics' site-specific PEGylation technology to develop a treatment for antiphospholipid syndrome (APS). PolyTherics will own rights to develop and commercialize treatments...